LDS/Medical Tests/Thyroglobulin Antibody

Thyroglobulin Antibody

Thyroglobulin (Tg) is a large glycoprotein found in the follicular cells of the thyroid. Thyroglobulin along with the enzyme thyroid-specific peroxidase (TPO) plays an important role in the production of thyroid hormones T3 and T4. Thyroglobulin serves as a progenitor for thyroid hormones. When the thyroid gland is stimulated, thyroglobulin is degraded and the thyroid hormones T3 and T4 are released into the bloodstream. The measurement of autoantibody against thyroglobulin is useful in identifying patients with autoimmune thyroid disease. Although the level of anti-Tg autoantibody is increased in 80% to 100% of patients with Hashimoto’s chronic thyroiditis, 60% to 70% of patients with Graves’ disease, and in 10% to 20% of patients with subacute thyroiditis, this assay is not specific and should be used with other markers. The sensitivity of the procedure can be increased by simultaneously determining additional thyroid antibodies (anti-TPO, TSH-receptor-antibodies). In addition, a negative result does not definitively rule out the presence of an autoimmune disease. Titers that are elevated initially can become negative if the disease persists for a long period of time or if remission occurs. If antibody reappears after remission, a relapse is likely. Anti-thyroglobulin antibody can be detected in other non-thyroid disease states, in elderly patients, and also in clinically normal euthyroid patients. Anti-Tg antibody has been detected in patients with idiopathic Addison’s disease and in some patients with Type I diabetes mellitus.
  • Diagnosis of autoimmune thyroid diseases including Hashimoto’s thyroiditis and Graves’ disease
  • Differential diagnosis of autoimmune thyroid disease of unknown origin with these negative anti-TPO diseases
  • Monitoring treatment and disease management
  • As an aid in diagnosis of Addison’s disease
  • Used to assess thyroglobulin value in patients with other thyroid disease where thyroglobulin levels are elevated, such as in secondary hyperthyroidism (e.g., thyroid tumors, thyroid neoplasia)

Increased in:

  • Hashimoto’s thyroiditis, thyrotoxicosis
  • Subacute thyroiditis
  • Graves’ disease
  • Also increased in autoimmune disorders such as systemic lupus erythematosus (SLE)
  • Pernicious anemia

Not increased in:

  • Multinodular goiter, thyroid adenomas, and some carcinomas

About 30 - 50% of patients with autoimmune hypothyroidism will have antibodies to thyroglobulin. Patients with thyroid cancer have an incidence of about 10 - 20% of anti thyroglobulin antibodies, and patients with Grave's disease will have about 15 - 25% of anti thyroglobulin antibodies.

Less than or equal to 60 IU/mL 

Chemiluminescent Immunoassay (CLIA), Enzyme immunoassay (EIA)

Serum (SST)

Stability

  • Ambient: 5 days
  • Refrigerated: 7 days
  • Frozen: 60 days
Thyroglobulin, Thyroid Stimulating Hormone (TSH), T3, T4, Anti Thyroid peroxidase antibody (Anti-TPO), Anti-Thyrotropin receptor antibody, Thyroid stimulating immunoglobulin, Comprehensive Metabolic Panel.
Within 1 day after receipt in performing laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Ann Clin Biochem. 2006;43(Pt 3):173. [PMID: 16704751]
  • Clin Chem. 1996 Jan;42(1):160-3. [PMID: 8565220]
  • Thyroid. 2004 Jul;14(7):510-20. [PMID: 15307940]
  • Autoimmunity. 2003 Sep-Nov;36(6-7):361-6. [PMID: 14669943]
  • Endocrinol Metab Clin North Am. 2001 Jun;30(2):429-67. [PMID: 11444170]
  • Appl Biochem Biotechnol. 2000 Jan-Mar;83(1-3):245-51. [PMID: 10826964]
  • J Clin Endocrinol Metab. 1998 Apr;83(4):1121-7. [PMID: 9543128]
  • Endocrinol Metab Clin North Am. 1995 Dec;24(4):841-63. [PMID: 8608781]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757